PATENT CLAIM ANALYSIS

Application Number: 16109570
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["424", "186100"]

Abstract:
The present disclosure encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs are formed by the CPV VP2 protein. Further, the disclosure broadly encompasses vaccines comprising combinations of MLV and VLP, which are capable of overcoming MDA against a variety of pathogens, which infect a variety of different species.

Claim (Index 20):
The method of  claim 19 , wherein the VLPs comprise a CPV polypeptide having 90% or greater sequence identity to at least one of SEQ ID NOs: 1, 3, 4, 6, 8, 9, and 10.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 96.0
- Lexical Diversity: 1.66667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15265545', '14863181', '15537081', '15317593', '13324887']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.725732335966863
- 35 USC 102 Novelty (BERT): 0.6025487699756822
- Combined Prediction Score: 0.713413979367745
- Mean Citation Score: 316.0094640000001
- Max Citation Score: 613.0885599999998
- Similarity Product: 434.7043771669052

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test